insights_auto
Por que MVIR caiu 7,12%?
Saiba maischevron_right
MVIR:STO
Medivir AB
SEK 1,04
arrow_downward
-7,12%(-0,080) 1D
20 de nov., 17:29:48 +1 GMT · SEK
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para MVIR…
Abrir
SEK 1,12
Alta
SEK 1,13
Baixa
SEK 1,03
Valor de mercado
653,97 mi
Volume médio
2,05 mi
Volume
2,43 mi
Alto — 52 sem
SEK 2,88
Baixo — 52 sem
SEK 0,34
LPA
-SEK 0,27
Ações em circulação
624,18 mi
Nº de funcionários
7
Abrir
SEK 1,12
Alta
SEK 1,13
Baixa
SEK 1,03
Valor de mercado
653,97 mi
Volume médio
2,05 mi
Volume
2,43 mi
Alto — 52 sem
SEK 2,88
Baixo — 52 sem
SEK 0,34
LPA
-SEK 0,27
Ações em circulação
624,18 mi
Nº de funcionários
7
Notícias
De fontes da web e parceiros de notícias
AP News
·
há 14 horas
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
Trefis
·
há 4 horas
25 S&P 500 Stocks Just Made New 52-Week Lows
Beinsure
·
há 3 horas
S&P 500 forecast for 2027: Wall Street expects a rebound after an 11.6% drop fueled by AI fears
Yahoo Finance
·
há 16 horas
Wall St ends sharply lower on AI selloff, S&P 500, Dow in correction
Perfil
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Sobre Medivir AB